CDKN2A and cancer: The result showed that there was no significant difference in the expression of SLC2A3 between normal and cancer tissues; the expression of CDKN2A in cancer tissues was higher than that in normal tissues (p<0.01); the expression of FABP4 in cancer tissues was lower than that in normal tissues (p<0.01) (Figures 9A–C).